Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study.

Awareness patient perspective qualitative study quality of life systemic lupus erythematosus

Journal

Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265

Informations de publication

Date de publication:
05 Apr 2024
Historique:
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 5 4 2024
Statut: aheadofprint

Résumé

Systemic lupus erythematosus (SLE) is an autoimmune condition that can highly impact patients' quality of life (QoL). However, there is a lack of knowledge about SLE, affecting the general population and health care professionals (HCPs) alike. This lack of knowledge has negative implications for patients and the healthcare system, worsening prognosis, negatively impacting QoL, and increasing healthcare utilization. The aim of this paper is to draw attention, according to the perspective of the participants of this study, to the lack of awareness of SLE and its consequences in Spain, and to suggest improvements. This qualitative, descriptive, observational, multicenter, and cross-sectional study included 40 patients with moderate or severe SLE, recruited during their routine visits in six university hospitals in Spain. The study also included 11 caregivers and 9 HCPs. All participants were individually interviewed. Data from the interviews were coded and analyzed thematically by two anthropologists following a phenomenological perspective. Our study identified a lack of disease awareness among primary care physicians, emergency medicine doctors, and other specialists treating SLE symptomatology. This led to diagnostic delays, which had a clinical and emotional impact on patients. Furthermore, symptom awareness was found to be context dependent. Differences in symptom awareness between HCPs and patients led to a mismatch between the severity evaluation made by doctors and patients. Some HCPs did not consider the limitations of the current severity evaluation of SLE, and therefore attributed symptoms potentially caused by SLE to the unfavorable socioeconomic conditions patients lived in. Finally, a lack of social awareness among friends, family members, and romantic partners led to lower social support, increased isolation, and negative physical and emotional impact for patients. Gender differences in the provision of support were identified. This study highlights the need to increase SLE awareness among patients, HCPs, and the broader public in order to improve patient QoL. Being aware of the clinical and emotional impact of such lack of awareness, as well as the role played by context on the patient experience of SLE, is a crucial step towards achieving this goal.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Systemic lupus erythematosus (SLE) is an autoimmune condition that can highly impact patients' quality of life (QoL). However, there is a lack of knowledge about SLE, affecting the general population and health care professionals (HCPs) alike. This lack of knowledge has negative implications for patients and the healthcare system, worsening prognosis, negatively impacting QoL, and increasing healthcare utilization. The aim of this paper is to draw attention, according to the perspective of the participants of this study, to the lack of awareness of SLE and its consequences in Spain, and to suggest improvements.
PATIENTS AND METHODS METHODS
This qualitative, descriptive, observational, multicenter, and cross-sectional study included 40 patients with moderate or severe SLE, recruited during their routine visits in six university hospitals in Spain. The study also included 11 caregivers and 9 HCPs. All participants were individually interviewed. Data from the interviews were coded and analyzed thematically by two anthropologists following a phenomenological perspective.
RESULTS RESULTS
Our study identified a lack of disease awareness among primary care physicians, emergency medicine doctors, and other specialists treating SLE symptomatology. This led to diagnostic delays, which had a clinical and emotional impact on patients. Furthermore, symptom awareness was found to be context dependent. Differences in symptom awareness between HCPs and patients led to a mismatch between the severity evaluation made by doctors and patients. Some HCPs did not consider the limitations of the current severity evaluation of SLE, and therefore attributed symptoms potentially caused by SLE to the unfavorable socioeconomic conditions patients lived in. Finally, a lack of social awareness among friends, family members, and romantic partners led to lower social support, increased isolation, and negative physical and emotional impact for patients. Gender differences in the provision of support were identified.
CONCLUSION CONCLUSIONS
This study highlights the need to increase SLE awareness among patients, HCPs, and the broader public in order to improve patient QoL. Being aware of the clinical and emotional impact of such lack of awareness, as well as the role played by context on the patient experience of SLE, is a crucial step towards achieving this goal.

Identifiants

pubmed: 38577967
doi: 10.1177/09612033241242886
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9612033241242886

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: RRR and CSM are employees of A Piece of Pie and have received research funding from AstraZeneca to conduct this study. JSH, MG, and NBR are employees of AstraZeneca. ERA has received honoraria from GSK. All other authors report no competing interests.

Auteurs

Maria Galindo Izquierdo (M)

Rheumatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.

Joaquín Borrás Blasco (J)

Hospital Pharmacy, Hospital de Sagunto, Sagunto, Spain.

Silvia Pérez Ortega (S)

President of FELUPUS (Spanish Lupus Federation), Madrid, Spain.

Tarek Carlos Salman-Monte (TC)

Rheumatology Department, Hospital del Mar, Barcelona, Spain.

Paloma Vela-Casasempere (P)

Rheumatology Department, Hospital General Universitario Dr Balmis Alicante/ISABIAL/Universidad Miguel Hernandez, Alicante, Spain.

Esther Rodríguez Almaraz (E)

Rheumatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.

Jaime Calvo-Alen (J)

Rheumatology Department, Hospital Universitario Araba, Instituto de Investigación BIORABA, Universidad del País Vasco, Vitoria-Gasteiz, Spain.

José María Álvaro-Gracia Álvaro (JM)

Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

M Julia Barbado Ajo (MJ)

Internal Medicine Department, Hospital Universitario Rio Hortega, Valladolid, Spain.

Raül Rubio Renau (R)

Evidence Generation Department, A Piece of Pie, Barcelona, Spain.

Marta Galvez-Fernandez (M)

Medical Department, AstraZeneca Farmacéutica Spain S.A., Madrid, Spain.

Noemí Bahamontes-Rosa (N)

Medical Department, AstraZeneca Farmacéutica Spain S.A., Madrid, Spain.

Joaquín Sánchez-Covisa Hernández (J)

Medical Department, AstraZeneca Farmacéutica Spain S.A., Madrid, Spain.

Carlota Solà Marsiñach (C)

Evidence Generation Department, A Piece of Pie, Barcelona, Spain.

Classifications MeSH